Search Results

Arthur Christopoulos is now live, titled "A Brief History of Allosteric Modulators."  Mark discussed this position with Beth Fleck, Director of In Vitro Pharmacology at Crinetics Pharmaceuticals receptor pharmacology Structural and dynamic insights into the activation of the μ-opioid receptor by an allosteric modulator Structural Insights into Partial Activation of the Prototypic G Protein-Coupled Adenosine Fellow—Pharmacology/Cell Biology/Biochemistry Post Doctoral Fellow Postdoc Position Senior Associate

State-dependent dynamics of extramembrane domains in the β2 -adrenergic receptor Signal transduction at GPCRs: Allosteric the ERK MAPK by β-arrestin GPCR Binders, Drugs, and more Pharmacologically targeting intracellular allosteric GPCR shapes behavior Methods & Updates in GPCR Research Advancements in the use of xenopus oocytes for modelling of the Year at the Citeline Pharma Intelligence Awards Japan 2023 BioMap and Sanofi to co-develop AI modules

– Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that it will issue its full-year 2021

dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor Allosteric modulation of the fish taste receptor type 1 (T1R) family by the extracellular chloride ion Illuminating with stable-isotope labeled receptors GPCR Binders, Drugs, and more Orthosteric ligand selectivity and allosteric infections predominate after day 100 following B-cell maturation antigen-directed CAR T-cell therapy SSTR2 positively medicine in the treatment of glioblastoma multiforme Industry News Structure Therapeutics Announces Positive

Ozempic® cost; Nxera launches obesity pipeline; Superluminal–Lilly cardiometabolic partnership; New GPCR allosteric the potentiation of GPCR signaling by ATP and sugar monophosphates and the identification of a novel allosteric Threat Avoided:  Prevent costly late-stage failures by incorporating kinetic modeling early in your pipeline Stay informed on emerging public health threats and the scientific research aimed at addressing them, positioning

Career opportunities:  A curated list of new positions, including a Research Associate, a Senior Research Scientist, and a Post-doctoral Researcher position focused on GPCRs and Mitochondria. Must-read publications:  New insights on RGS protein modulation, GRK2-biased β₂AR signaling, and the If you’re not there, you’re missing out on the next wave of allosteric modulators, biased ligands, and Gain a competitive edge by staying on top of the latest breakthroughs in allostery, biased signaling,

Ligand Activation in NMBR Simulations show how two ligands differently activate class A GPCR NMBR, with allosteric communication hubs modulating signaling, advancing antipruritic drug strategies.

GPCR Symposium on 'GPCRs as Therapeutic Modalities'. beta-barrel transporters and their AlphaFold2 predicted water-soluble QTY variants Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain Industry News Superluminal Medicines Discovery On Target September 27 - 28, 2023 | Training Seminar "The Renaissance in GPCRs as Drug Targets: Allosteric

October 2022 Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics approach of combining the data derived from steered molecular dynamics simulations and the Bell-Evans model

, can effectively measure the strength of an allosteric effect as agonist's efficacy Single transmembrane GPCR modulating proteins: neither single nor simple Structural and Molecular Insights into GPCR Function selectivity and antagonism in extracellular GPCR-nanobodies Industry News Structure Therapeutics Reports Positive Medical Affairs Septerna to Participate in the Jefferies Global Healthcare Conference Crinetics Announces Positive Fellow—Pharmacology/Cell Biology/Biochemistry Post Doctoral Fellow Postdoc Position Join Dr.

vitro and in situ chemical crosslinking, disulfide pattern analysis, and mutation data with molecular modeling to generate experimentally driven full-length models. These models provide insights into the interface, important side-chain interactions, and activation mechanism The models are expected to allow for testable hypotheses about signal transduction and drug development

Additionally, we detect a shortening of PC in PINK1-deficient human cellular and mouse models of familial Furthermore, in sPD models, the shortening of PC is accompanied by increased Sonic Hedgehog (SHH) signal

A Rab10-ACAP1-Arf6 GTPases cascade modulates M4 muscarinic acetylcholine receptor trafficking and signaling Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator. α1-adrenoceptor Endogenous l- to d-amino acid residue isomerization modulates selectivity between distinct neuropeptide (July 2 - 7, 2023). 3rd Annual Meeting IRN I-GPCRNet (October 25 - 27, 2023) GPCR Jobs Postdoctoral positions

But in Melbourne, a quiet experiment challenged that model — and it worked. Funding models rewarded independence, not shared resources. Engineering Collaboration: The Monash Lab Model Traditional academic labs mirror feudal structures. The Monash model flipped that logic: Shared infrastructure, not duplicated equipment Centralized core What Changed After This Data The pooled funding model turned the lab into a magnet: postdocs, visiting

Dopamine D2 receptor modulators  – transforming treatment for Parkinson’s & schizophrenia. Allosteric modulation  for unprecedented precision. Serotonin & dopamine receptor modulation  for neuropsychiatric disorders. These sessions bridge structural biology , computational modeling , and clinical translation  — with

2022 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today reported its half-year and second quarter financial

peptides designed from the intracellular loops of G protein-coupled receptors (GPCRs) that act in an allosteric manner to modulate the activity of GPCRs.

Signaling Sonja Peter , Brian Bender , Chris De Graaf   for their excellent work on Comparative Study of Allosteric infection: IUPHAR Review 41 Structural and Molecular Insights into GPCR Function Comparative Study of Allosteric

By modulating receptor expression or sensitivity, we can shift the “lens” through which drug activity Model patient-like pathophysiological states (e.g., reduced receptor expression in heart failure). Adjusting assay sensitivity—whether through expression systems, chemical modulation, or engineered desensitization—provides What emerges is not just more data—it’s the right data, positioned to inform strategic decision-making If you’re still treating orthosteric and allosteric interactions as interchangeable, you’re leaving precision

factor-dependent phosphorylation of Gαi shapes canonical signaling by G protein-coupled receptors Kinetic Model epithelial cells GPCR Binders, Drugs, and more Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1 GPCR function in autophagy control: a systematic approach of chemical Treg Depleting anti-CCR8 Antibodies, Including Best-in-class Candidate DT-7012 Crinetics Announces Positive Fellow—Pharmacology/Cell Biology/Biochemistry Post Doctoral Fellow Postdoc Position Join Dr.

analysis of a series of GPCRs whose activity has been shown to affect the lifespan of animal and human models

Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it has entered into a definitive

agonism by Gαi/o-biased stapled peptide agonists of the relaxin-3 receptor GPCR kinases differentially modulate cannabinoid receptor agonists at the cannabinoid CB1 receptor Why classical receptor theory, which ignores allostery , can effectively measure the strength of an allosteric effect as agonist's efficacy GPCR Binders, Drugs Imaging Center Scientific Assistant Postdoctoral Fellowship- Mechanistic Biology Research Scientist Post-Doc position Join Dr.

Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it has entered into a definitive

They stall when chemistry, modeling, and pharmacology drift apart. Breakthroughs this week: 12th Adhesion GPCR Workshop (Düsseldorf, Sept 16–18, 2026); Free fatty acid receptor 2 allosterism These sessions span foundational pharmacology, receptor biology, modeling, translational strategy, and partnership connects advanced assay and biology capabilities with the scientists and organizations positioned

disturbances GPCR Binders, Drugs, and more Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of β2-adrenergic receptors GPCRs in Neuroscience In-silico predicted mouse melanopsins with Caenorhabditis elegans Calcium-sensing receptor regulates Kv7 channels via Gi/o protein signalling and modulates antigens enable drug discovery and development Mapping GPCR-RAMP complexes with MolBoolean Screening GPR75 Modulators Postdoctoral research position Senior or Lead Researcher   Senior Scientist, Cryo-Electron Microscopy

Breakthroughs this week: C. elegans avoids EGCG via SRXA-7 GPCR; a bidirectional GPCR switch modulates immune signaling; a machine-learning tool predicts GPCR–ligand kinetics; and cryo-EM uncovers a new allosteric We kick off with a question that cuts deep: What if your models could actually predict the future? Jens Carlsson  (Uppsala University) joins Yamina  to explore how computational modeling is evolving from

From restricted tissue diffusion to PK–PD dissociation, Kenakin equips you with the kinetic models and In This Session, You’ll Gain: ✅ Modeling tools to understand how restricted diffusion  in tissues like window ✅ Examples of how rebinding in dense receptor environments  amplifies target occupancy, even post-clearance PK–PD Dissociation: When Clearance Doesn’t Mean It’s Over The lecture’s standout example: Aplaviroc, an allosteric Kenakin offers not just theory, but tools to model, predict, and validate this behavior early.

Monitoring intracellular cAMP levels can help identify orthosteric agonists and antagonists, as well as allosteric modulators.

Mandibulofacial dysostosis with alopecia results from gain-of-ETAR function via allosteric effects on GPCR Binders, Drugs, and more Modelling altered signalling of G-protein coupled receptors in inflamed GPCR Allostery: a View from Computational Biology.